Close
Smartlab Europe
Inizio Ignite

Press Releases

SAL launches its pharma facilities at KFIA Cargo Village

Saudi Arabian Logistics (SAL) has launched the operations of its state-of-the-art pharma facilities recently opened at the Dammam-based King Fahad International Airport’s Cargo Village. The new warehouses will support the infrastructure of pharma and medical equipment handling facilities as per...

Clarify Health Releases Next-Generation Analytics to Help Pharma and Biotech Commercial Teams Optimize Drug Launches

Clarify Health, a leading healthcare analytics company, announced that its life sciences software, Clarify Launch, now includes innovative enhancements that give brand teams a faster and more effective way to identify market opportunities to drive growth. The ability to...

ERT Continues to Drive Innovation in Virtualization for Respiratory Clinical Trials

ERT, the global leader in clinical endpoints data collection, announced a strategic partnership with Inofab Health, a healthcare technology company designing and developing ultrasonic spirometry technology for in-clinic and at-home use. Through the partnership, ERT expands its portfolio of...

Allmpus Laboratories Embraces Local Manufacturing of Pharmaceutical Essentials

Allmpus Laboratories, one of India’s leading research-based pharmaceutical enterprise, is turning to local manufacturing for Pharma essentials. The initiative is taken to localise supply networks and reduce dependency on other countries for raw materials and Active Pharmaceutical Ingredients (APIs)...

Freyr Launches Covid-19 Web Platform for Manufacturers

Freyr, a leading global Regulatory solutions and services company, announces the launch of a powerful web platform for Covid-19 driven with real-time information for manufacturers to make them go to the markets, right in time and support them in...

Avalon GloboCare Announces Successful Completion of Phase I Clinical Study of CAR T-Cell Therapy Candidate AVA-001

Avalon GloboCare Corp., a clinical-stage global developer of cell-based technologies and therapeutics, announced it has successfully completed Phase I first-in-human clinical study of its leading Chimeric Antigen Receptor (CAR) T-cell therapy candidate, AVA-001 (National Institute of Health clinical trial...

GSK receives first regulatory approval for Duvroq in Japan for patients with anaemia due to chronic kidney disease

GlaxoSmithKline plc announced the approval of a Japanese New Drug Application (JNDA) by the Ministry of Health, Labour and Welfare for Duvroq (daprodustat) tablets, an oral hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI), for the treatment of patients with anaemia...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate »